Trump Administration Shuts Down Medicare Coverage for GLP-1s: DOWNSIZED NEWS скачать в хорошем качестве

Trump Administration Shuts Down Medicare Coverage for GLP-1s: DOWNSIZED NEWS

Latest GLP-1 News: Medicare Coverage Shutdown, HHS Cutbacks, and Big Pharma's Moves In this episode of 'The Downsized News,' Laraine and Christopher Durham discuss significant updates in the world of GLP-1 medications. Key highlights include the Trump administration's halting of a Biden-era Medicare expansion plan, which would have covered GLP-1 medications for obesity, impacting over 7 million people. They also cover the introduction of Eli Lilly's weight loss drug Zepbound on the telehealth platform HIMS and hers, despite Lilly's lack of affiliation. Another major story is the reduction of the HHS workforce by 25% under Secretary Robert F. Kennedy Jr., raising concerns about the future of FDA's oversight and drug approval processes. Additionally, Novo Holdings reports a record $8.7 billion profit, while Novo Nordisk seeks FDA approval to expand the use of its oral GLP-1, Rybelsus, for reducing heart disease risk in type 2 diabetics. Scientists behind GLP-1 medications win the prestigious Breakthrough Prize in Life Sciences, further legitimizing the treatment of obesity as a disease. Lastly, Eli Lilly and Novo Nordisk intensify their social media campaigns against compounded versions of their medications, highlighting the ongoing battle between big pharma and compounding pharmacies. This episode is packed with critical information affecting both the accessibility and affordability of GLP-1 treatments. BOOK THE DOWNSIZED AT SEA CRUISE: https://thedownsized.org/downsized-at... DOWNSIZED WEBSITE: https://thedownsized.org/ DOWNSIZED GLP-1 COMPANION PRODUCT STORE: https://thedownsized.org/downsized-store JOIN CLUB DOWNSIZED: / @thedownsized FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/ 00:00 Introduction and Today's Headlines 01:32 Trump Administration Shuts Down Medicare Coverage for GLP-1 Medications 05:32 HIMS and Hers Offers Zepbound at a High Pice 07:39 Massive Job Cuts at HHS Ordered by RFK Jr. 11:39 Novo Holdings' Record Profits and Investments 14:12 Rybelsus Seeks FDA Approval for Heart Disease Risk Reduction 16:06 Breakthrough Prize for GLP-1 Scientists 19:14 Big Pharma's War on Compounding Pharmacies 23:28 Conclusion and Final Thoughts